PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors - PubMed (original) (raw)
. 2007 Jun 1;109(11):4671-8.
doi: 10.1182/blood-2006-09-044826. Epub 2007 Feb 1.
Zheng Zhang, Xicheng Wang, Jun-Liang Fu, Jinxia Yao, Yanmei Jiao, Liangen Chen, Hui Zhang, Jianan Wei, Lei Jin, Ming Shi, George Fu Gao, Hao Wu, Fu-Sheng Wang
Affiliations
- PMID: 17272504
- DOI: 10.1182/blood-2006-09-044826
Free article
PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors
Ji-Yuan Zhang et al. Blood. 2007.
Free article
Abstract
The immunoreceptor PD-1 is significantly up-regulated on exhausted CD8+ T cells during chronic viral infections such as HIV-1. However, it remains unknown whether PD-1 expression on CD8+ T cells differs between typical progressors (TPs) and long-term nonprogressors (LTNPs). In this report, we examined PD-1 expression on HIV-specific CD8+ T cells from 63 adults with chronic HIV infection. We found that LTNPs exhibited functional HIV-specific memory CD8+ T cells with markedly lower PD-1 expression. TPs, in contrast, showed significantly up-regulated PD-1 expression that was closely correlated with a reduction in CD4 T-cell number and an elevation in plasma viral load. Importantly, PD-1 up-regulation was also associated with reduced perforin and IFN-gamma production, as well as decreased HIV-specific effector memory CD8+ T-cell proliferation in TPs but not LTNPs. Blocking PD-1/PD-L1 interactions efficiently restored HIV-specific CD8+ T-cell effector function and proliferation. Taken together, these findings confirm the hypothesis that high PD-1 up-regulation mediates HIV-specific CD8+ T-cell exhaustion. Blocking the PD-1/PD-L1 pathway may represent a new therapeutic option for this disease and provide more insight into immune pathogenesis in LTNPs.
Similar articles
- PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, Mncube Z, Duraiswamy J, Zhu B, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJ, Klenerman P, Ahmed R, Freeman GJ, Walker BD. Day CL, et al. Nature. 2006 Sep 21;443(7109):350-4. doi: 10.1038/nature05115. Epub 2006 Aug 20. Nature. 2006. PMID: 16921384 - Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
D'Souza M, Fontenot AP, Mack DG, Lozupone C, Dillon S, Meditz A, Wilson CC, Connick E, Palmer BE. D'Souza M, et al. J Immunol. 2007 Aug 1;179(3):1979-87. doi: 10.4049/jimmunol.179.3.1979. J Immunol. 2007. PMID: 17641065 - Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.
Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS, Routy JP, Haddad EK, Sekaly RP. Trautmann L, et al. Nat Med. 2006 Oct;12(10):1198-202. doi: 10.1038/nm1482. Epub 2006 Aug 20. Nat Med. 2006. PMID: 16917489 - Role of PD-1 in HIV pathogenesis and as target for therapy.
Porichis F, Kaufmann DE. Porichis F, et al. Curr HIV/AIDS Rep. 2012 Mar;9(1):81-90. doi: 10.1007/s11904-011-0106-4. Curr HIV/AIDS Rep. 2012. PMID: 22198819 Free PMC article. Review. - Malaria drives T cells to exhaustion.
Wykes MN, Horne-Debets JM, Leow CY, Karunarathne DS. Wykes MN, et al. Front Microbiol. 2014 May 27;5:249. doi: 10.3389/fmicb.2014.00249. eCollection 2014. Front Microbiol. 2014. PMID: 24904561 Free PMC article. Review.
Cited by
- HIV specific CD8+ TRM-like cells in tonsils express exhaustive signatures in the absence of natural HIV control.
Fardoos R, Nyquist SK, Asowata OE, Kazer SW, Singh A, Ngoepe A, Giandhari J, Mthabela N, Ramjit D, Singh S, Karim F, Buus S, Anderson F, Porterfield JZ, Sibiya AL, Bipath R, Moodley K, Kuhn W, Berger B, Nguyen S, de Oliveira T, Ndung'u T, Goulder P, Shalek AK, Leslie A, Kløverpris HN. Fardoos R, et al. Front Immunol. 2022 Oct 18;13:912038. doi: 10.3389/fimmu.2022.912038. eCollection 2022. Front Immunol. 2022. PMID: 36330531 Free PMC article. - Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.
Manuel SL, Sehgal M, Connolly J, Makedonas G, Khan ZK, Gardner J, Betts MR, Jain P. Manuel SL, et al. J Clin Immunol. 2013 Oct;33(7):1223-39. doi: 10.1007/s10875-013-9918-x. Epub 2013 Jul 26. J Clin Immunol. 2013. PMID: 23888327 Free PMC article. - Immune Control of HIV.
Balasubramaniam M, Pandhare J, Dash C. Balasubramaniam M, et al. J Life Sci (Westlake Village). 2019 Jun;1(1):4-37. J Life Sci (Westlake Village). 2019. PMID: 31468033 Free PMC article. - Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway.
Lages CS, Lewkowich I, Sproles A, Wills-Karp M, Chougnet C. Lages CS, et al. Aging Cell. 2010 Oct;9(5):785-98. doi: 10.1111/j.1474-9726.2010.00611.x. Aging Cell. 2010. PMID: 20653631 Free PMC article. - Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients.
Zhang Z, Fu J, Xu X, Wang S, Xu R, Zhao M, Nie W, Wang X, Zhang J, Li T, Su L, Wang FS. Zhang Z, et al. AIDS. 2013 May 15;27(8):1283-93. doi: 10.1097/QAD.0b013e32835fab77. AIDS. 2013. PMID: 23925377 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous